External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ERA 2026
Roche and Genentech at

ERA 2026

June 03 - June 06
Glasgow, UK
era-online.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:27 AM
Duration 6mins Glasgow, UK
Correlating Matched First Morning Void And 24-Hour Urine Protein-To-Creatinine Ratios: An Exploratory Analysis of the REGENCY trial
Rachel Jones, Brad H. Rovin, Elsa Martins, Jay Garg, Liz Lightstone, Brian Rayner, Gustavo Aroca-Martínez, Bongin Yoo, Theodore A. Omachi, Thomas Schindler, William F. Pendergraft, Ana Malvar
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:45 AM
Duration 6mins Glasgow, UK
Obinutuzumab Promotes Early Kidney Tubular Repair and Regeneration in Lupus Nephritis: REGENCY Post hoc Analyses of Urine Epidermal Growth Factor
Brad H. Rovin, Rachel Jones, Holly J. Clarke, Ben Lanza, Theodore A. Omachi, William F. Pendergraft III, Harini Raghu, Juan M. Mejia-Vilet
Nephrology - Rheumatology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:10 AM
Duration 15mins Glasgow, UK
The MAJESTY Trial: Obinutuzumab versus Tacrolimus in Primary Membranous Nephropathy
Fernando Fervenza, Chuanming Hao, Gianna Kirsztajn, Loreto Gesualdo, Tomasz Hryszko, Antonio Pisani, Dario Roccatello, Jay Garg, Thomas Schindler, Sunny Pokala, Eriola Berisha, Ana Malvar
Nephrology | Membranous glomerulonephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:25 AM
Duration 10mins Glasgow, UK
Efficacy, safety and pharmacokinetics/pharmacodynamics of crovalimab▼ for paediatric atypical haemolytic uraemic syndrome: Phase III COMMUTE-p trial
Maria Helena Vaisbich, Bradley Dixon, Fadi Fakhouri, Anne-Laure Lapeyraque, Teri Jo Mauch, Sidharth Kumar Sethi, Aditi Sinha, Patty Leon, Muriel Buri , Sasha Sreckovic, Laurence Greenbaum
Nephrology | Atypical hemolytic uremic syndrome

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:35 AM
Duration 10mins Glasgow, UK
Efficacy, safety and pharmacokinetics/pharmacodynamics of crovalimab▼ for atypical haemolytic uraemic syndrome (aHUS): Phase III COMMUTE-a trial
Bradley Dixon, Paul Brinkkötter, Spero Cataland, Necmi Eren, Benjamin Gomez, David Machado, Yoshitaka Miyakawa, Luis Gustavo Modelli, Pedro Augusto Macedo de Souza, Francesca Chiara Viazzi, Sonia Khemais, Ming-hui Zhao
Nephrology | Atypical Hemolytic Uremic Syndrome

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.